Literature DB >> 18714299

PCR-amplification of GC-rich regions: 'slowdown PCR'.

Ulrich H Frey1, Hagen S Bachmann, Jürgen Peters, Winfried Siffert.   

Abstract

The polymerase chain reaction (PCR) technique has become an indispensable method in molecular research. However, PCR-amplification of GC-rich templates is often hampered by the formation of secondary structures like hairpins and higher melting temperatures. We present a novel method termed 'Slowdown PCR', which allows the successful PCR-amplification of extremely GC-rich (>83%) DNA targets. The protocol relies on the addition of 7-deaza-2'-deoxyguanosine, a dGTP analog to the PCR mixture and a novel standardized cycling protocol with varying temperatures. The latter consists of a generally lowered ramp rate of 2.5 degrees C s(-1) and a low cooling rate of 1.5 degrees C s(-1) for reaching an annealing temperature and is run for 48 cycles. We established this protocol as a versatile method not only for amplification of extremely GC-rich regions, but also for routine DNA diagnostics and pharmacogenetics for templates with different annealing temperatures. The protocol takes 5 h to complete.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18714299     DOI: 10.1038/nprot.2008.112

Source DB:  PubMed          Journal:  Nat Protoc        ISSN: 1750-2799            Impact factor:   13.491


  42 in total

1.  Amplification of GC-rich DNA for high-throughput family-based genetic studies.

Authors:  Sadaf Naz; Amara Fatima
Journal:  Mol Biotechnol       Date:  2013-03       Impact factor: 2.695

2.  Genetic and epigenetic regulation of AHR gene expression in MCF-7 breast cancer cells: role of the proximal promoter GC-rich region.

Authors:  Neal A Englert; Robert J Turesky; Weiguo Han; Erin E Bessette; Simon D Spivack; Michele Caggana; David C Spink; Barbara C Spink
Journal:  Biochem Pharmacol       Date:  2012-06-21       Impact factor: 5.858

3.  GNAS gene variants affect β-blocker-related survival after coronary artery bypass grafting.

Authors:  Ulrich H Frey; Jochen D Muehlschlegel; Jürgen Peters; Simon Body; Christoph Ochterbeck; Amanda A Fox; Stanton K Shernan; Charles D Collard; Peter Lichtner
Journal:  Anesthesiology       Date:  2014-05       Impact factor: 7.892

4.  Screening ancient tuberculosis with qPCR: challenges and opportunities.

Authors:  Kelly M Harkins; Jane E Buikstra; Tessa Campbell; Kirsten I Bos; Eric D Johnson; Johannes Krause; Anne C Stone
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2015-01-19       Impact factor: 6.237

5.  A Set of Assays for the Comprehensive Analysis of FMR1 Alleles in the Fragile X-Related Disorders.

Authors:  Bruce E Hayward; Yifan Zhou; Daman Kumari; Karen Usdin
Journal:  J Mol Diagn       Date:  2016-08-12       Impact factor: 5.568

6.  Easy-to-use strategy for reference gene selection in quantitative real-time PCR experiments.

Authors:  Stefanie Klenke; Kristina Renckhoff; Andrea Engler; Jürgen Peters; Ulrich H Frey
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2016-09-20       Impact factor: 3.000

7.  Up-regulation of Cavβ3 subunit in primary sensory neurons increases voltage-activated Ca2+ channel activity and nociceptive input in neuropathic pain.

Authors:  Li Li; Xue-Hong Cao; Shao-Rui Chen; Hee-Dong Han; Gabriel Lopez-Berestein; Anil K Sood; Hui-Lin Pan
Journal:  J Biol Chem       Date:  2011-12-20       Impact factor: 5.157

8.  Fast evolving 18S rRNA sequences from Solenogastres (Mollusca) resist standard PCR amplification and give new insights into mollusk substitution rate heterogeneity.

Authors:  Achim Meyer; Christiane Todt; Nina T Mikkelsen; Bernhard Lieb
Journal:  BMC Evol Biol       Date:  2010-03-09       Impact factor: 3.260

9.  DMSO and betaine greatly improve amplification of GC-rich constructs in de novo synthesis.

Authors:  Michael A Jensen; Marilyn Fukushima; Ronald W Davis
Journal:  PLoS One       Date:  2010-06-11       Impact factor: 3.240

10.  Comprehensive cloning of patient-derived 9022-bp amplicons of hepatitis C virus.

Authors:  Yang Lu; Yanjuan Xu; Adrian M Di Bisceglie; Xiaofeng Fan
Journal:  J Virol Methods       Date:  2013-04-17       Impact factor: 2.014

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.